| Page Range | 13801-13802 | |
| FR Document | 2016-05744 |
[Federal Register Volume 81, Number 50 (Tuesday, March 15, 2016)] [Notices] [Pages 13801-13802] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-05744] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2015-N-3815] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Electronic Submission of Medical Device Registration and Listing AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by April 14, 2016. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-7285, or emailed to [email protected]. All comments should be identified with the OMB control number 0910-0625. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002, [email protected]. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Electronic Submission of Medical Device Registration and Listing--21 CFR Part 807, Subparts A Through D; OMB Control Number 0910-0625-- Extension Under section 510 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360) and part 807, subparts A through D (21 CFR part 807, subparts A through D), medical device establishment owners and operators are required to electronically submit establishment registration and device listing information. Complete and accurate registration and listing information is necessary to accomplish a number of statutory and regulatory objectives, such as: (1) Identification of establishments producing marketed medical devices, (2) identification of establishments producing a specific device when that device is in short supply or is needed for national emergency, (3) facilitation of recalls for devices marketed by owners and operators of device establishments, (4) identification and cataloguing of marketed devices, (5) administering postmarketing surveillance programs for devices, (6) identification of devices marketed in violation of the law, (7) identification and control of devices imported into the country from foreign establishments, (8) and scheduling and planning inspections of registered establishments under section 704 of the FD&C Act (21 U.S.C. 374). Respondents to this information collection are owners or operators of establishments that engage in the manufacturing, preparation, propagation, compounding, or processing of a device or devices, who must register their establishments and submit listing information for each of their devices in commercial distribution. Notwithstanding certain exceptions, foreign device establishments that manufacture, prepare, propagate, compound, or process a device that is imported or offered for import into the United States must also comply with the registration and listing requirements. The number of respondents is based on data from the FDA Unified Registration and Listing System. Burden estimates are based on recent experience with the existing medical device registration and listing program, electronic system operating experience, and the economic analysis for the final rule entitled ``Implementation of Device Registration and Listing Requirements Enacted in the Public Health Security and Bioterrorism Preparedness and Response Act of 2002, the Medical Device User Fee and Modernization Act of 2002, and Title II of the Food and Drug Administration Amendments Act of 2007.'' In the Federal Register of October 27, 2015 (80 FR 65779), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received. FDA estimates the burden of this collection of information as follows: Table 1--Estimated Annual Reporting Burden \1\ -------------------------------------------------------------------------------------------------------------------------------------------------------- Number of 21 CFR Section FDA Form No. Number of responses per Total annual Average burden per response Total hours respondents respondent responses -------------------------------------------------------------------------------------------------------------------------------------------------------- 807.20(a)(5) \2\--Submittal of 3673 8,594 1 8,594 1.75.......................... 15,040 manufacturer information by initial importers. 807.20(a)(5) \3\--Submittal of 3673 8,594 3 25,782 .1............................ 2,578 manufacturer information by initial (6 minutes)................... importers. [[Page 13802]] 807.21(a) \3\--Creation of electronic 3673 3,559 1 3,559 .5............................ 1,780 system account. (30 minutes).................. 807.21(b) \2\--Annual request for waiver .............. 14 1 14 1............................. 14 from electronic registration and listing. 807.21(b) \3\--Initial request for .............. 4 1 4 1............................. 4 waiver from electronic registration and listing. 807.22(a) \3\--Initial registration and 3673 3,539 1 3,539 .5............................ 1,770 listing. (30 minutes).................. 807.22(b)(1) \3\--Annual registration... 3673 20,355 1 20,355 .75........................... 15,266 (45 minutes).................. 807.22(b)(2) \3\--Other updates of 3673 4,176 1 4,176 .5............................ 2,088 registration. (30 minutes).................. 807.22(b)(3) \3\--Annual update of 3673 19,875 1 19,875 1............................. 19,875 listing information. 807.26(e) \3\--Labeling and .............. 71 1 71 1............................. 71 advertisement submitted at FDA request. 807.34(a) \2\--Initial registration and .............. 14 1 14 1............................. 14 listing when electronic filing waiver granted. 807.34(a) \3\--Annual registration and .............. 4 1 4 1............................. 4 listing when electronic filing waiver granted. 807.40(b)(2) \3\--Annual update of U.S. 3673 1,615 1 1,615 .5............................ 808 agent information. (30 minutes).................. 807.40(b)(3) \3\--U.S. agent responses 3673 1,535 1 1,535 .25........................... 384 to FDA requests for information. (15 minutes).................. 807.41(a) \3\--Identification of initial 3673 10,329 1 10,329 .5............................ 5,165 importers by foreign establishments. (30 minutes).................. 807.41(b) \3\--Identification of other 3673 10,329 1 10,329 .5............................ 5,165 parties that facilitate import by (30 minutes).................. foreign establishments. --------------------------------------------------------------------------------------------------------------- Total one-time burden............... .............. .............. .............. .............. .............................. 15,068 --------------------------------------------------------------------------------------------------------------- Total recurring burden.............. .............. .............. .............. .............. .............................. 54,958 -------------------------------------------------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. \2\ One-time burden. \3\ Recurring burden. Table 2--Estimated Annual Recordkeeping Burden \1\ ---------------------------------------------------------------------------------------------------------------- Number of 21 CFR Section Number of records per Total annual Average burden per Total hours recordkeepers recordkeeper records recordkeeping ---------------------------------------------------------------------------------------------------------------- 807.25(d) \2\--List of 23,806 1 23,806 .25............... 5,952 officers, directors and (30 minutes)...... partners. 807.26 \2\--Labeling and 11,746 4 46,984 .5................ 23,492 advertisements available (30 minutes)...... for review. ----------------------------------------------------------------------------------- Total................... .............. .............. .............. .................. 29,444 ---------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. \2\ Recurring burden. Dated: March 9, 2016. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2016-05744 Filed 3-14-16; 8:45 am] BILLING CODE 4164-01-P
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | Fax written comments on the collection of information by April 14, 2016. | |
| Contact | FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002, [email protected] | |
| FR Citation | 81 FR 13801 |